Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Suspended × OTHER_GOV × Clear all

Phase

Phase NA 6 Phase 2 2 Phase 4 1 Phase 3 1

Status

Unknown 34 Completed 24 Recruiting 8 Withdrawn 3 Terminated 3 Not yet recruiting 2 Suspended 1

Sponsor Class

OTHER 4 INDUSTRY 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01320501 2016-05-13

REALME

National Guard Health Affairs

Phase 4 Suspended

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡